The heart failure markers natriuretic peptides A and B (Nppa and Nppb, respectively) were significantly overexpressed in the DOXO-only group and remained significantly higher in the mirabegron-treated DOXO group compared to the control group (Table 5). Here, NPPB is linked to heart failure.